June 2024

Evertis launches Evercare™ brand, set to be a leading provider of specialty and innovative medical-gradefilms designed to provide superior performance and support regulatory compliance to the healthcare market. Evercare™ is built on over 65 years of trusted technical Evertis experience in developing PET and PETG films for regulated applications that meet sustainability credentials, and now compliant in meeting the rigorous needs of the healthcare industry.

Evercare™ sits in avertically integrated Group that delivers a unique value proposition to Healthcare customers in terms of innovation, sustainability and supply chain security. As film converters for packaging, Evertis is integrated with Selenis,a premium supplier of innovative copolyesters resins with solutions specifically developed, and certified for the medical value chain to further support patient safety. As a Group it fully understands and plays its part in circularity whilst reducing the carbon footprint of its products.

Evercare™ PET and PETG drop-in solutions offer performance and sustainability advantages when compared to other materials. Their films facilitate the thermoforming process, provide improved mechanical and optical properties, and have a better resistance to sterilization. Manufactured in strict compliance with GMP standards and support regulatory compliance needs, Evercare™ films are offered with declarations such as ISO10993, USP661.1, ISO11607, as well as change notification.

Gonzalo Lopez-Oleaga, Evertis Europe Deputy CEO said; “This is another key milestone in the journeyof our Group of businesses. As innovators and thought leaders in polyester-based materials we are now positioned to help healthcare companies meet their sustainability packaging goals, now, and into the future. Behind Evercare™ we have made large investments operationally, in technology and most importantly GMP manufacturing supported by full certifications to service this market”.

Similar to other industries, the healthcare packaging industry faces the challenges of improving sustainability. This is why the Evercare product range not only offers plug&play recyclable PET based solutions, but also two other sustainable options: bio-based and chemically recycled materials with up to 50% post-consumer recycled (PCR) content. All of these options take advantage of vertical integration with Selenis, meeting the same quality and regulatory standards and representing a great opportunity to lower carbon footprint.

Casimiro Sacchetti, CSO Evertis Americas said; “It’s an exciting and unique offering for the Healthcare market. It’s the coming together of experience, deep technical knowledge underpinned by a truly integrated, vertical operational set-up from resin production to extrusion of medical-grade films. With the innovative Evercare™ film range we are actively supporting the move of our medical & pharma customers towards safe and ecofriendly packaging solutions.”

-

Reduction in environmental pollution and emissions as waste is reused 

-

Material for insulation purposes

-

High durability

-

Easy to store and transport

-

Simple and low-cost technique

-

More than 14 communities and 128 families participated

-

1,725 eco-bricks were recollected

-

8,000 USD in vouchers for supermarkets were distributed to the families who participated – a huge relief in COVID times

-

110,350 m2 of waste was recycled

-

More than 110,350 m2 of constructions will be built

June 2024

Evertis launches Evercare™ brand, set to be a leading provider of specialty and innovative medical-gradefilms designed to provide superior performance and support regulatory compliance to the healthcare market. Evercare™ is built on over 65 years of trusted technical Evertis experience in developing PET and PETG films for regulated applications that meet sustainability credentials, and now compliant in meeting the rigorous needs of the healthcare industry.

Evercare™ sits in avertically integrated Group that delivers a unique value proposition to Healthcare customers in terms of innovation, sustainability and supply chain security. As film converters for packaging, Evertis is integrated with Selenis,a premium supplier of innovative copolyesters resins with solutions specifically developed, and certified for the medical value chain to further support patient safety. As a Group it fully understands and plays its part in circularity whilst reducing the carbon footprint of its products.

Evercare™ PET and PETG drop-in solutions offer performance and sustainability advantages when compared to other materials. Their films facilitate the thermoforming process, provide improved mechanical and optical properties, and have a better resistance to sterilization. Manufactured in strict compliance with GMP standards and support regulatory compliance needs, Evercare™ films are offered with declarations such as ISO10993, USP661.1, ISO11607, as well as change notification.

Gonzalo Lopez-Oleaga, Evertis Europe Deputy CEO said; “This is another key milestone in the journeyof our Group of businesses. As innovators and thought leaders in polyester-based materials we are now positioned to help healthcare companies meet their sustainability packaging goals, now, and into the future. Behind Evercare™ we have made large investments operationally, in technology and most importantly GMP manufacturing supported by full certifications to service this market”.

Similar to other industries, the healthcare packaging industry faces the challenges of improving sustainability. This is why the Evercare product range not only offers plug&play recyclable PET based solutions, but also two other sustainable options: bio-based and chemically recycled materials with up to 50% post-consumer recycled (PCR) content. All of these options take advantage of vertical integration with Selenis, meeting the same quality and regulatory standards and representing a great opportunity to lower carbon footprint.

Casimiro Sacchetti, CSO Evertis Americas said; “It’s an exciting and unique offering for the Healthcare market. It’s the coming together of experience, deep technical knowledge underpinned by a truly integrated, vertical operational set-up from resin production to extrusion of medical-grade films. With the innovative Evercare™ film range we are actively supporting the move of our medical & pharma customers towards safe and ecofriendly packaging solutions.”

June 2024

Evertis launches Evercare™ brand, set to be a leading provider of specialty and innovative medical-gradefilms designed to provide superior performance and support regulatory compliance to the healthcare market. Evercare™ is built on over 65 years of trusted technical Evertis experience in developing PET and PETG films for regulated applications that meet sustainability credentials, and now compliant in meeting the rigorous needs of the healthcare industry.

Evercare™ sits in avertically integrated Group that delivers a unique value proposition to Healthcare customers in terms of innovation, sustainability and supply chain security. As film converters for packaging, Evertis is integrated with Selenis,a premium supplier of innovative copolyesters resins with solutions specifically developed, and certified for the medical value chain to further support patient safety. As a Group it fully understands and plays its part in circularity whilst reducing the carbon footprint of its products.

Evercare™ PET and PETG drop-in solutions offer performance and sustainability advantages when compared to other materials. Their films facilitate the thermoforming process, provide improved mechanical and optical properties, and have a better resistance to sterilization. Manufactured in strict compliance with GMP standards and support regulatory compliance needs, Evercare™ films are offered with declarations such as ISO10993, USP661.1, ISO11607, as well as change notification.

Gonzalo Lopez-Oleaga, Evertis Europe Deputy CEO said; “This is another key milestone in the journeyof our Group of businesses. As innovators and thought leaders in polyester-based materials we are now positioned to help healthcare companies meet their sustainability packaging goals, now, and into the future. Behind Evercare™ we have made large investments operationally, in technology and most importantly GMP manufacturing supported by full certifications to service this market”.

Similar to other industries, the healthcare packaging industry faces the challenges of improving sustainability. This is why the Evercare product range not only offers plug&play recyclable PET based solutions, but also two other sustainable options: bio-based and chemically recycled materials with up to 50% post-consumer recycled (PCR) content. All of these options take advantage of vertical integration with Selenis, meeting the same quality and regulatory standards and representing a great opportunity to lower carbon footprint.

Casimiro Sacchetti, CSO Evertis Americas said; “It’s an exciting and unique offering for the Healthcare market. It’s the coming together of experience, deep technical knowledge underpinned by a truly integrated, vertical operational set-up from resin production to extrusion of medical-grade films. With the innovative Evercare™ film range we are actively supporting the move of our medical & pharma customers towards safe and ecofriendly packaging solutions.”

June 2024

Evertis launches Evercare™ brand, set to be a leading provider of specialty and innovative medical-gradefilms designed to provide superior performance and support regulatory compliance to the healthcare market. Evercare™ is built on over 65 years of trusted technical Evertis experience in developing PET and PETG films for regulated applications that meet sustainability credentials, and now compliant in meeting the rigorous needs of the healthcare industry.

Evercare™ sits in avertically integrated Group that delivers a unique value proposition to Healthcare customers in terms of innovation, sustainability and supply chain security. As film converters for packaging, Evertis is integrated with Selenis,a premium supplier of innovative copolyesters resins with solutions specifically developed, and certified for the medical value chain to further support patient safety. As a Group it fully understands and plays its part in circularity whilst reducing the carbon footprint of its products.

Evercare™ PET and PETG drop-in solutions offer performance and sustainability advantages when compared to other materials. Their films facilitate the thermoforming process, provide improved mechanical and optical properties, and have a better resistance to sterilization. Manufactured in strict compliance with GMP standards and support regulatory compliance needs, Evercare™ films are offered with declarations such as ISO10993, USP661.1, ISO11607, as well as change notification.

Gonzalo Lopez-Oleaga, Evertis Europe Deputy CEO said; “This is another key milestone in the journeyof our Group of businesses. As innovators and thought leaders in polyester-based materials we are now positioned to help healthcare companies meet their sustainability packaging goals, now, and into the future. Behind Evercare™ we have made large investments operationally, in technology and most importantly GMP manufacturing supported by full certifications to service this market”.

Similar to other industries, the healthcare packaging industry faces the challenges of improving sustainability. This is why the Evercare product range not only offers plug&play recyclable PET based solutions, but also two other sustainable options: bio-based and chemically recycled materials with up to 50% post-consumer recycled (PCR) content. All of these options take advantage of vertical integration with Selenis, meeting the same quality and regulatory standards and representing a great opportunity to lower carbon footprint.

Casimiro Sacchetti, CSO Evertis Americas said; “It’s an exciting and unique offering for the Healthcare market. It’s the coming together of experience, deep technical knowledge underpinned by a truly integrated, vertical operational set-up from resin production to extrusion of medical-grade films. With the innovative Evercare™ film range we are actively supporting the move of our medical & pharma customers towards safe and ecofriendly packaging solutions.”

EVERTIS’ TRAY-TO-TRAY SOLUTION IS DEVELOPED UNDER THEIR CIRCULAR ECONOMY PLEDGE

June 2024

Evertis launches Evercare™ brand, set to be a leading provider of specialty and innovative medical-gradefilms designed to provide superior performance and support regulatory compliance to the healthcare market. Evercare™ is built on over 65 years of trusted technical Evertis experience in developing PET and PETG films for regulated applications that meet sustainability credentials, and now compliant in meeting the rigorous needs of the healthcare industry.

Evercare™ sits in avertically integrated Group that delivers a unique value proposition to Healthcare customers in terms of innovation, sustainability and supply chain security. As film converters for packaging, Evertis is integrated with Selenis,a premium supplier of innovative copolyesters resins with solutions specifically developed, and certified for the medical value chain to further support patient safety. As a Group it fully understands and plays its part in circularity whilst reducing the carbon footprint of its products.

Evercare™ PET and PETG drop-in solutions offer performance and sustainability advantages when compared to other materials. Their films facilitate the thermoforming process, provide improved mechanical and optical properties, and have a better resistance to sterilization. Manufactured in strict compliance with GMP standards and support regulatory compliance needs, Evercare™ films are offered with declarations such as ISO10993, USP661.1, ISO11607, as well as change notification.

Gonzalo Lopez-Oleaga, Evertis Europe Deputy CEO said; “This is another key milestone in the journeyof our Group of businesses. As innovators and thought leaders in polyester-based materials we are now positioned to help healthcare companies meet their sustainability packaging goals, now, and into the future. Behind Evercare™ we have made large investments operationally, in technology and most importantly GMP manufacturing supported by full certifications to service this market”.

Similar to other industries, the healthcare packaging industry faces the challenges of improving sustainability. This is why the Evercare product range not only offers plug&play recyclable PET based solutions, but also two other sustainable options: bio-based and chemically recycled materials with up to 50% post-consumer recycled (PCR) content. All of these options take advantage of vertical integration with Selenis, meeting the same quality and regulatory standards and representing a great opportunity to lower carbon footprint.

Casimiro Sacchetti, CSO Evertis Americas said; “It’s an exciting and unique offering for the Healthcare market. It’s the coming together of experience, deep technical knowledge underpinned by a truly integrated, vertical operational set-up from resin production to extrusion of medical-grade films. With the innovative Evercare™ film range we are actively supporting the move of our medical & pharma customers towards safe and ecofriendly packaging solutions.”

June 2024

Evertis launches Evercare™ brand, set to be a leading provider of specialty and innovative medical-gradefilms designed to provide superior performance and support regulatory compliance to the healthcare market. Evercare™ is built on over 65 years of trusted technical Evertis experience in developing PET and PETG films for regulated applications that meet sustainability credentials, and now compliant in meeting the rigorous needs of the healthcare industry.

Evercare™ sits in avertically integrated Group that delivers a unique value proposition to Healthcare customers in terms of innovation, sustainability and supply chain security. As film converters for packaging, Evertis is integrated with Selenis,a premium supplier of innovative copolyesters resins with solutions specifically developed, and certified for the medical value chain to further support patient safety. As a Group it fully understands and plays its part in circularity whilst reducing the carbon footprint of its products.

Evercare™ PET and PETG drop-in solutions offer performance and sustainability advantages when compared to other materials. Their films facilitate the thermoforming process, provide improved mechanical and optical properties, and have a better resistance to sterilization. Manufactured in strict compliance with GMP standards and support regulatory compliance needs, Evercare™ films are offered with declarations such as ISO10993, USP661.1, ISO11607, as well as change notification.

Gonzalo Lopez-Oleaga, Evertis Europe Deputy CEO said; “This is another key milestone in the journeyof our Group of businesses. As innovators and thought leaders in polyester-based materials we are now positioned to help healthcare companies meet their sustainability packaging goals, now, and into the future. Behind Evercare™ we have made large investments operationally, in technology and most importantly GMP manufacturing supported by full certifications to service this market”.

Similar to other industries, the healthcare packaging industry faces the challenges of improving sustainability. This is why the Evercare product range not only offers plug&play recyclable PET based solutions, but also two other sustainable options: bio-based and chemically recycled materials with up to 50% post-consumer recycled (PCR) content. All of these options take advantage of vertical integration with Selenis, meeting the same quality and regulatory standards and representing a great opportunity to lower carbon footprint.

Casimiro Sacchetti, CSO Evertis Americas said; “It’s an exciting and unique offering for the Healthcare market. It’s the coming together of experience, deep technical knowledge underpinned by a truly integrated, vertical operational set-up from resin production to extrusion of medical-grade films. With the innovative Evercare™ film range we are actively supporting the move of our medical & pharma customers towards safe and ecofriendly packaging solutions.”

-

Rationalising the use of energy and natural resources and act on the processes in order to optimise and reduceconsumption.

-

Reducing the production of waste by increasing and promoting recycling and recovering material wheneverpossible.

-

Ensuring that materials and procedures used don’t present any risk to the health of workers and to the environment.

-

Making sure that the use of materials, resources and the incorporation of safe and innovative technologies promoteenvironmental protection and minimise the environmental impacts.

-

Coaching and engaging employees to perform in a conscious and responsible manner, for the importance ofeveryone in guaranteeing product safety and for improving environmental performance.

-

Implementing good practices in order to comply with applicable legislation and other requirements that will leadto the environmental preservation.

June 2024

Evertis launches Evercare™ brand, set to be a leading provider of specialty and innovative medical-gradefilms designed to provide superior performance and support regulatory compliance to the healthcare market. Evercare™ is built on over 65 years of trusted technical Evertis experience in developing PET and PETG films for regulated applications that meet sustainability credentials, and now compliant in meeting the rigorous needs of the healthcare industry.

Evercare™ sits in avertically integrated Group that delivers a unique value proposition to Healthcare customers in terms of innovation, sustainability and supply chain security. As film converters for packaging, Evertis is integrated with Selenis,a premium supplier of innovative copolyesters resins with solutions specifically developed, and certified for the medical value chain to further support patient safety. As a Group it fully understands and plays its part in circularity whilst reducing the carbon footprint of its products.

Evercare™ PET and PETG drop-in solutions offer performance and sustainability advantages when compared to other materials. Their films facilitate the thermoforming process, provide improved mechanical and optical properties, and have a better resistance to sterilization. Manufactured in strict compliance with GMP standards and support regulatory compliance needs, Evercare™ films are offered with declarations such as ISO10993, USP661.1, ISO11607, as well as change notification.

Gonzalo Lopez-Oleaga, Evertis Europe Deputy CEO said; “This is another key milestone in the journeyof our Group of businesses. As innovators and thought leaders in polyester-based materials we are now positioned to help healthcare companies meet their sustainability packaging goals, now, and into the future. Behind Evercare™ we have made large investments operationally, in technology and most importantly GMP manufacturing supported by full certifications to service this market”.

Similar to other industries, the healthcare packaging industry faces the challenges of improving sustainability. This is why the Evercare product range not only offers plug&play recyclable PET based solutions, but also two other sustainable options: bio-based and chemically recycled materials with up to 50% post-consumer recycled (PCR) content. All of these options take advantage of vertical integration with Selenis, meeting the same quality and regulatory standards and representing a great opportunity to lower carbon footprint.

Casimiro Sacchetti, CSO Evertis Americas said; “It’s an exciting and unique offering for the Healthcare market. It’s the coming together of experience, deep technical knowledge underpinned by a truly integrated, vertical operational set-up from resin production to extrusion of medical-grade films. With the innovative Evercare™ film range we are actively supporting the move of our medical & pharma customers towards safe and ecofriendly packaging solutions.”

June 2024

Evertis launches Evercare™ brand, set to be a leading provider of specialty and innovative medical-gradefilms designed to provide superior performance and support regulatory compliance to the healthcare market. Evercare™ is built on over 65 years of trusted technical Evertis experience in developing PET and PETG films for regulated applications that meet sustainability credentials, and now compliant in meeting the rigorous needs of the healthcare industry.

Evercare™ sits in avertically integrated Group that delivers a unique value proposition to Healthcare customers in terms of innovation, sustainability and supply chain security. As film converters for packaging, Evertis is integrated with Selenis,a premium supplier of innovative copolyesters resins with solutions specifically developed, and certified for the medical value chain to further support patient safety. As a Group it fully understands and plays its part in circularity whilst reducing the carbon footprint of its products.

Evercare™ PET and PETG drop-in solutions offer performance and sustainability advantages when compared to other materials. Their films facilitate the thermoforming process, provide improved mechanical and optical properties, and have a better resistance to sterilization. Manufactured in strict compliance with GMP standards and support regulatory compliance needs, Evercare™ films are offered with declarations such as ISO10993, USP661.1, ISO11607, as well as change notification.

Gonzalo Lopez-Oleaga, Evertis Europe Deputy CEO said; “This is another key milestone in the journeyof our Group of businesses. As innovators and thought leaders in polyester-based materials we are now positioned to help healthcare companies meet their sustainability packaging goals, now, and into the future. Behind Evercare™ we have made large investments operationally, in technology and most importantly GMP manufacturing supported by full certifications to service this market”.

Similar to other industries, the healthcare packaging industry faces the challenges of improving sustainability. This is why the Evercare product range not only offers plug&play recyclable PET based solutions, but also two other sustainable options: bio-based and chemically recycled materials with up to 50% post-consumer recycled (PCR) content. All of these options take advantage of vertical integration with Selenis, meeting the same quality and regulatory standards and representing a great opportunity to lower carbon footprint.

Casimiro Sacchetti, CSO Evertis Americas said; “It’s an exciting and unique offering for the Healthcare market. It’s the coming together of experience, deep technical knowledge underpinned by a truly integrated, vertical operational set-up from resin production to extrusion of medical-grade films. With the innovative Evercare™ film range we are actively supporting the move of our medical & pharma customers towards safe and ecofriendly packaging solutions.”

June 2024

Evertis launches Evercare™ brand, set to be a leading provider of specialty and innovative medical-gradefilms designed to provide superior performance and support regulatory compliance to the healthcare market. Evercare™ is built on over 65 years of trusted technical Evertis experience in developing PET and PETG films for regulated applications that meet sustainability credentials, and now compliant in meeting the rigorous needs of the healthcare industry.

Evercare™ sits in avertically integrated Group that delivers a unique value proposition to Healthcare customers in terms of innovation, sustainability and supply chain security. As film converters for packaging, Evertis is integrated with Selenis,a premium supplier of innovative copolyesters resins with solutions specifically developed, and certified for the medical value chain to further support patient safety. As a Group it fully understands and plays its part in circularity whilst reducing the carbon footprint of its products.

Evercare™ PET and PETG drop-in solutions offer performance and sustainability advantages when compared to other materials. Their films facilitate the thermoforming process, provide improved mechanical and optical properties, and have a better resistance to sterilization. Manufactured in strict compliance with GMP standards and support regulatory compliance needs, Evercare™ films are offered with declarations such as ISO10993, USP661.1, ISO11607, as well as change notification.

Gonzalo Lopez-Oleaga, Evertis Europe Deputy CEO said; “This is another key milestone in the journeyof our Group of businesses. As innovators and thought leaders in polyester-based materials we are now positioned to help healthcare companies meet their sustainability packaging goals, now, and into the future. Behind Evercare™ we have made large investments operationally, in technology and most importantly GMP manufacturing supported by full certifications to service this market”.

Similar to other industries, the healthcare packaging industry faces the challenges of improving sustainability. This is why the Evercare product range not only offers plug&play recyclable PET based solutions, but also two other sustainable options: bio-based and chemically recycled materials with up to 50% post-consumer recycled (PCR) content. All of these options take advantage of vertical integration with Selenis, meeting the same quality and regulatory standards and representing a great opportunity to lower carbon footprint.

Casimiro Sacchetti, CSO Evertis Americas said; “It’s an exciting and unique offering for the Healthcare market. It’s the coming together of experience, deep technical knowledge underpinned by a truly integrated, vertical operational set-up from resin production to extrusion of medical-grade films. With the innovative Evercare™ film range we are actively supporting the move of our medical & pharma customers towards safe and ecofriendly packaging solutions.”

-

Four partners have collaborated on an industry-leading recycling approach

-

Closed-loop economy for PET-based multilayer Green Deal-compliant

-

Further collaborations are planned to optimize the process harnessing water-based adhesive technology

June 2024

Evertis launches Evercare™ brand, set to be a leading provider of specialty and innovative medical-gradefilms designed to provide superior performance and support regulatory compliance to the healthcare market. Evercare™ is built on over 65 years of trusted technical Evertis experience in developing PET and PETG films for regulated applications that meet sustainability credentials, and now compliant in meeting the rigorous needs of the healthcare industry.

Evercare™ sits in avertically integrated Group that delivers a unique value proposition to Healthcare customers in terms of innovation, sustainability and supply chain security. As film converters for packaging, Evertis is integrated with Selenis,a premium supplier of innovative copolyesters resins with solutions specifically developed, and certified for the medical value chain to further support patient safety. As a Group it fully understands and plays its part in circularity whilst reducing the carbon footprint of its products.

Evercare™ PET and PETG drop-in solutions offer performance and sustainability advantages when compared to other materials. Their films facilitate the thermoforming process, provide improved mechanical and optical properties, and have a better resistance to sterilization. Manufactured in strict compliance with GMP standards and support regulatory compliance needs, Evercare™ films are offered with declarations such as ISO10993, USP661.1, ISO11607, as well as change notification.

Gonzalo Lopez-Oleaga, Evertis Europe Deputy CEO said; “This is another key milestone in the journeyof our Group of businesses. As innovators and thought leaders in polyester-based materials we are now positioned to help healthcare companies meet their sustainability packaging goals, now, and into the future. Behind Evercare™ we have made large investments operationally, in technology and most importantly GMP manufacturing supported by full certifications to service this market”.

Similar to other industries, the healthcare packaging industry faces the challenges of improving sustainability. This is why the Evercare product range not only offers plug&play recyclable PET based solutions, but also two other sustainable options: bio-based and chemically recycled materials with up to 50% post-consumer recycled (PCR) content. All of these options take advantage of vertical integration with Selenis, meeting the same quality and regulatory standards and representing a great opportunity to lower carbon footprint.

Casimiro Sacchetti, CSO Evertis Americas said; “It’s an exciting and unique offering for the Healthcare market. It’s the coming together of experience, deep technical knowledge underpinned by a truly integrated, vertical operational set-up from resin production to extrusion of medical-grade films. With the innovative Evercare™ film range we are actively supporting the move of our medical & pharma customers towards safe and ecofriendly packaging solutions.”

June 2024

Evertis launches Evercare™ brand, set to be a leading provider of specialty and innovative medical-gradefilms designed to provide superior performance and support regulatory compliance to the healthcare market. Evercare™ is built on over 65 years of trusted technical Evertis experience in developing PET and PETG films for regulated applications that meet sustainability credentials, and now compliant in meeting the rigorous needs of the healthcare industry.

Evercare™ sits in avertically integrated Group that delivers a unique value proposition to Healthcare customers in terms of innovation, sustainability and supply chain security. As film converters for packaging, Evertis is integrated with Selenis,a premium supplier of innovative copolyesters resins with solutions specifically developed, and certified for the medical value chain to further support patient safety. As a Group it fully understands and plays its part in circularity whilst reducing the carbon footprint of its products.

Evercare™ PET and PETG drop-in solutions offer performance and sustainability advantages when compared to other materials. Their films facilitate the thermoforming process, provide improved mechanical and optical properties, and have a better resistance to sterilization. Manufactured in strict compliance with GMP standards and support regulatory compliance needs, Evercare™ films are offered with declarations such as ISO10993, USP661.1, ISO11607, as well as change notification.

Gonzalo Lopez-Oleaga, Evertis Europe Deputy CEO said; “This is another key milestone in the journeyof our Group of businesses. As innovators and thought leaders in polyester-based materials we are now positioned to help healthcare companies meet their sustainability packaging goals, now, and into the future. Behind Evercare™ we have made large investments operationally, in technology and most importantly GMP manufacturing supported by full certifications to service this market”.

Similar to other industries, the healthcare packaging industry faces the challenges of improving sustainability. This is why the Evercare product range not only offers plug&play recyclable PET based solutions, but also two other sustainable options: bio-based and chemically recycled materials with up to 50% post-consumer recycled (PCR) content. All of these options take advantage of vertical integration with Selenis, meeting the same quality and regulatory standards and representing a great opportunity to lower carbon footprint.

Casimiro Sacchetti, CSO Evertis Americas said; “It’s an exciting and unique offering for the Healthcare market. It’s the coming together of experience, deep technical knowledge underpinned by a truly integrated, vertical operational set-up from resin production to extrusion of medical-grade films. With the innovative Evercare™ film range we are actively supporting the move of our medical & pharma customers towards safe and ecofriendly packaging solutions.”

June 2024

Evertis launches Evercare™ brand, set to be a leading provider of specialty and innovative medical-gradefilms designed to provide superior performance and support regulatory compliance to the healthcare market. Evercare™ is built on over 65 years of trusted technical Evertis experience in developing PET and PETG films for regulated applications that meet sustainability credentials, and now compliant in meeting the rigorous needs of the healthcare industry.

Evercare™ sits in avertically integrated Group that delivers a unique value proposition to Healthcare customers in terms of innovation, sustainability and supply chain security. As film converters for packaging, Evertis is integrated with Selenis,a premium supplier of innovative copolyesters resins with solutions specifically developed, and certified for the medical value chain to further support patient safety. As a Group it fully understands and plays its part in circularity whilst reducing the carbon footprint of its products.

Evercare™ PET and PETG drop-in solutions offer performance and sustainability advantages when compared to other materials. Their films facilitate the thermoforming process, provide improved mechanical and optical properties, and have a better resistance to sterilization. Manufactured in strict compliance with GMP standards and support regulatory compliance needs, Evercare™ films are offered with declarations such as ISO10993, USP661.1, ISO11607, as well as change notification.

Gonzalo Lopez-Oleaga, Evertis Europe Deputy CEO said; “This is another key milestone in the journeyof our Group of businesses. As innovators and thought leaders in polyester-based materials we are now positioned to help healthcare companies meet their sustainability packaging goals, now, and into the future. Behind Evercare™ we have made large investments operationally, in technology and most importantly GMP manufacturing supported by full certifications to service this market”.

Similar to other industries, the healthcare packaging industry faces the challenges of improving sustainability. This is why the Evercare product range not only offers plug&play recyclable PET based solutions, but also two other sustainable options: bio-based and chemically recycled materials with up to 50% post-consumer recycled (PCR) content. All of these options take advantage of vertical integration with Selenis, meeting the same quality and regulatory standards and representing a great opportunity to lower carbon footprint.

Casimiro Sacchetti, CSO Evertis Americas said; “It’s an exciting and unique offering for the Healthcare market. It’s the coming together of experience, deep technical knowledge underpinned by a truly integrated, vertical operational set-up from resin production to extrusion of medical-grade films. With the innovative Evercare™ film range we are actively supporting the move of our medical & pharma customers towards safe and ecofriendly packaging solutions.”

June 2024

Evertis launches Evercare™ brand, set to be a leading provider of specialty and innovative medical-gradefilms designed to provide superior performance and support regulatory compliance to the healthcare market. Evercare™ is built on over 65 years of trusted technical Evertis experience in developing PET and PETG films for regulated applications that meet sustainability credentials, and now compliant in meeting the rigorous needs of the healthcare industry.

Evercare™ sits in avertically integrated Group that delivers a unique value proposition to Healthcare customers in terms of innovation, sustainability and supply chain security. As film converters for packaging, Evertis is integrated with Selenis,a premium supplier of innovative copolyesters resins with solutions specifically developed, and certified for the medical value chain to further support patient safety. As a Group it fully understands and plays its part in circularity whilst reducing the carbon footprint of its products.

Evercare™ PET and PETG drop-in solutions offer performance and sustainability advantages when compared to other materials. Their films facilitate the thermoforming process, provide improved mechanical and optical properties, and have a better resistance to sterilization. Manufactured in strict compliance with GMP standards and support regulatory compliance needs, Evercare™ films are offered with declarations such as ISO10993, USP661.1, ISO11607, as well as change notification.

Gonzalo Lopez-Oleaga, Evertis Europe Deputy CEO said; “This is another key milestone in the journeyof our Group of businesses. As innovators and thought leaders in polyester-based materials we are now positioned to help healthcare companies meet their sustainability packaging goals, now, and into the future. Behind Evercare™ we have made large investments operationally, in technology and most importantly GMP manufacturing supported by full certifications to service this market”.

Similar to other industries, the healthcare packaging industry faces the challenges of improving sustainability. This is why the Evercare product range not only offers plug&play recyclable PET based solutions, but also two other sustainable options: bio-based and chemically recycled materials with up to 50% post-consumer recycled (PCR) content. All of these options take advantage of vertical integration with Selenis, meeting the same quality and regulatory standards and representing a great opportunity to lower carbon footprint.

Casimiro Sacchetti, CSO Evertis Americas said; “It’s an exciting and unique offering for the Healthcare market. It’s the coming together of experience, deep technical knowledge underpinned by a truly integrated, vertical operational set-up from resin production to extrusion of medical-grade films. With the innovative Evercare™ film range we are actively supporting the move of our medical & pharma customers towards safe and ecofriendly packaging solutions.”

-

The traceability of the recycled raw materials involved in the manufacture of the film and the management of plastic waste resulting from the production process.

-

The percentage content of recycled plastic incorporated into the film manufactured over a certain period of analysis, in accordance with the EN 15343 standard.

June 2024

Evertis launches Evercare™ brand, set to be a leading provider of specialty and innovative medical-gradefilms designed to provide superior performance and support regulatory compliance to the healthcare market. Evercare™ is built on over 65 years of trusted technical Evertis experience in developing PET and PETG films for regulated applications that meet sustainability credentials, and now compliant in meeting the rigorous needs of the healthcare industry.

Evercare™ sits in avertically integrated Group that delivers a unique value proposition to Healthcare customers in terms of innovation, sustainability and supply chain security. As film converters for packaging, Evertis is integrated with Selenis,a premium supplier of innovative copolyesters resins with solutions specifically developed, and certified for the medical value chain to further support patient safety. As a Group it fully understands and plays its part in circularity whilst reducing the carbon footprint of its products.

Evercare™ PET and PETG drop-in solutions offer performance and sustainability advantages when compared to other materials. Their films facilitate the thermoforming process, provide improved mechanical and optical properties, and have a better resistance to sterilization. Manufactured in strict compliance with GMP standards and support regulatory compliance needs, Evercare™ films are offered with declarations such as ISO10993, USP661.1, ISO11607, as well as change notification.

Gonzalo Lopez-Oleaga, Evertis Europe Deputy CEO said; “This is another key milestone in the journeyof our Group of businesses. As innovators and thought leaders in polyester-based materials we are now positioned to help healthcare companies meet their sustainability packaging goals, now, and into the future. Behind Evercare™ we have made large investments operationally, in technology and most importantly GMP manufacturing supported by full certifications to service this market”.

Similar to other industries, the healthcare packaging industry faces the challenges of improving sustainability. This is why the Evercare product range not only offers plug&play recyclable PET based solutions, but also two other sustainable options: bio-based and chemically recycled materials with up to 50% post-consumer recycled (PCR) content. All of these options take advantage of vertical integration with Selenis, meeting the same quality and regulatory standards and representing a great opportunity to lower carbon footprint.

Casimiro Sacchetti, CSO Evertis Americas said; “It’s an exciting and unique offering for the Healthcare market. It’s the coming together of experience, deep technical knowledge underpinned by a truly integrated, vertical operational set-up from resin production to extrusion of medical-grade films. With the innovative Evercare™ film range we are actively supporting the move of our medical & pharma customers towards safe and ecofriendly packaging solutions.”

-

Rationalising the use of energy and natural resources and act on the processes to optimise and reduce consumption.

-

Reducing waste production by increasing and promoting the recycling and recovery of materials whenever possible.

-

Guaranteeing that the materials and procedures used don’t present any risk to the health of workers and the environment.

-

Ensuring that the use of materials, resources and the incorporation of safe and innovative technologies promote environmental protection and minimise environmental impacts.

-

Training and involving employees in conscious and responsible action, given the importance of everyone in ensuring product safety and improving environmental performance.

-

Implementing good practices in order to comply with applicable legislation and other requirements that lead to environmental preservation.

June 2024

Evertis launches Evercare™ brand, set to be a leading provider of specialty and innovative medical-gradefilms designed to provide superior performance and support regulatory compliance to the healthcare market. Evercare™ is built on over 65 years of trusted technical Evertis experience in developing PET and PETG films for regulated applications that meet sustainability credentials, and now compliant in meeting the rigorous needs of the healthcare industry.

Evercare™ sits in avertically integrated Group that delivers a unique value proposition to Healthcare customers in terms of innovation, sustainability and supply chain security. As film converters for packaging, Evertis is integrated with Selenis,a premium supplier of innovative copolyesters resins with solutions specifically developed, and certified for the medical value chain to further support patient safety. As a Group it fully understands and plays its part in circularity whilst reducing the carbon footprint of its products.

Evercare™ PET and PETG drop-in solutions offer performance and sustainability advantages when compared to other materials. Their films facilitate the thermoforming process, provide improved mechanical and optical properties, and have a better resistance to sterilization. Manufactured in strict compliance with GMP standards and support regulatory compliance needs, Evercare™ films are offered with declarations such as ISO10993, USP661.1, ISO11607, as well as change notification.

Gonzalo Lopez-Oleaga, Evertis Europe Deputy CEO said; “This is another key milestone in the journeyof our Group of businesses. As innovators and thought leaders in polyester-based materials we are now positioned to help healthcare companies meet their sustainability packaging goals, now, and into the future. Behind Evercare™ we have made large investments operationally, in technology and most importantly GMP manufacturing supported by full certifications to service this market”.

Similar to other industries, the healthcare packaging industry faces the challenges of improving sustainability. This is why the Evercare product range not only offers plug&play recyclable PET based solutions, but also two other sustainable options: bio-based and chemically recycled materials with up to 50% post-consumer recycled (PCR) content. All of these options take advantage of vertical integration with Selenis, meeting the same quality and regulatory standards and representing a great opportunity to lower carbon footprint.

Casimiro Sacchetti, CSO Evertis Americas said; “It’s an exciting and unique offering for the Healthcare market. It’s the coming together of experience, deep technical knowledge underpinned by a truly integrated, vertical operational set-up from resin production to extrusion of medical-grade films. With the innovative Evercare™ film range we are actively supporting the move of our medical & pharma customers towards safe and ecofriendly packaging solutions.”

2

Based on annual capacity

4

“Baseline report on plastic waste,” UNEP, 2020

June 2024

Evertis launches Evercare™ brand, set to be a leading provider of specialty and innovative medical-gradefilms designed to provide superior performance and support regulatory compliance to the healthcare market. Evercare™ is built on over 65 years of trusted technical Evertis experience in developing PET and PETG films for regulated applications that meet sustainability credentials, and now compliant in meeting the rigorous needs of the healthcare industry.

Evercare™ sits in avertically integrated Group that delivers a unique value proposition to Healthcare customers in terms of innovation, sustainability and supply chain security. As film converters for packaging, Evertis is integrated with Selenis,a premium supplier of innovative copolyesters resins with solutions specifically developed, and certified for the medical value chain to further support patient safety. As a Group it fully understands and plays its part in circularity whilst reducing the carbon footprint of its products.

Evercare™ PET and PETG drop-in solutions offer performance and sustainability advantages when compared to other materials. Their films facilitate the thermoforming process, provide improved mechanical and optical properties, and have a better resistance to sterilization. Manufactured in strict compliance with GMP standards and support regulatory compliance needs, Evercare™ films are offered with declarations such as ISO10993, USP661.1, ISO11607, as well as change notification.

Gonzalo Lopez-Oleaga, Evertis Europe Deputy CEO said; “This is another key milestone in the journeyof our Group of businesses. As innovators and thought leaders in polyester-based materials we are now positioned to help healthcare companies meet their sustainability packaging goals, now, and into the future. Behind Evercare™ we have made large investments operationally, in technology and most importantly GMP manufacturing supported by full certifications to service this market”.

Similar to other industries, the healthcare packaging industry faces the challenges of improving sustainability. This is why the Evercare product range not only offers plug&play recyclable PET based solutions, but also two other sustainable options: bio-based and chemically recycled materials with up to 50% post-consumer recycled (PCR) content. All of these options take advantage of vertical integration with Selenis, meeting the same quality and regulatory standards and representing a great opportunity to lower carbon footprint.

Casimiro Sacchetti, CSO Evertis Americas said; “It’s an exciting and unique offering for the Healthcare market. It’s the coming together of experience, deep technical knowledge underpinned by a truly integrated, vertical operational set-up from resin production to extrusion of medical-grade films. With the innovative Evercare™ film range we are actively supporting the move of our medical & pharma customers towards safe and ecofriendly packaging solutions.”

June 2024

Evertis launches Evercare™ brand, set to be a leading provider of specialty and innovative medical-gradefilms designed to provide superior performance and support regulatory compliance to the healthcare market. Evercare™ is built on over 65 years of trusted technical Evertis experience in developing PET and PETG films for regulated applications that meet sustainability credentials, and now compliant in meeting the rigorous needs of the healthcare industry.

Evercare™ sits in avertically integrated Group that delivers a unique value proposition to Healthcare customers in terms of innovation, sustainability and supply chain security. As film converters for packaging, Evertis is integrated with Selenis,a premium supplier of innovative copolyesters resins with solutions specifically developed, and certified for the medical value chain to further support patient safety. As a Group it fully understands and plays its part in circularity whilst reducing the carbon footprint of its products.

Evercare™ PET and PETG drop-in solutions offer performance and sustainability advantages when compared to other materials. Their films facilitate the thermoforming process, provide improved mechanical and optical properties, and have a better resistance to sterilization. Manufactured in strict compliance with GMP standards and support regulatory compliance needs, Evercare™ films are offered with declarations such as ISO10993, USP661.1, ISO11607, as well as change notification.

Gonzalo Lopez-Oleaga, Evertis Europe Deputy CEO said; “This is another key milestone in the journeyof our Group of businesses. As innovators and thought leaders in polyester-based materials we are now positioned to help healthcare companies meet their sustainability packaging goals, now, and into the future. Behind Evercare™ we have made large investments operationally, in technology and most importantly GMP manufacturing supported by full certifications to service this market”.

Similar to other industries, the healthcare packaging industry faces the challenges of improving sustainability. This is why the Evercare product range not only offers plug&play recyclable PET based solutions, but also two other sustainable options: bio-based and chemically recycled materials with up to 50% post-consumer recycled (PCR) content. All of these options take advantage of vertical integration with Selenis, meeting the same quality and regulatory standards and representing a great opportunity to lower carbon footprint.

Casimiro Sacchetti, CSO Evertis Americas said; “It’s an exciting and unique offering for the Healthcare market. It’s the coming together of experience, deep technical knowledge underpinned by a truly integrated, vertical operational set-up from resin production to extrusion of medical-grade films. With the innovative Evercare™ film range we are actively supporting the move of our medical & pharma customers towards safe and ecofriendly packaging solutions.”

June 2024

Evertis launches Evercare™ brand, set to be a leading provider of specialty and innovative medical-gradefilms designed to provide superior performance and support regulatory compliance to the healthcare market. Evercare™ is built on over 65 years of trusted technical Evertis experience in developing PET and PETG films for regulated applications that meet sustainability credentials, and now compliant in meeting the rigorous needs of the healthcare industry.

Evercare™ sits in avertically integrated Group that delivers a unique value proposition to Healthcare customers in terms of innovation, sustainability and supply chain security. As film converters for packaging, Evertis is integrated with Selenis,a premium supplier of innovative copolyesters resins with solutions specifically developed, and certified for the medical value chain to further support patient safety. As a Group it fully understands and plays its part in circularity whilst reducing the carbon footprint of its products.

Evercare™ PET and PETG drop-in solutions offer performance and sustainability advantages when compared to other materials. Their films facilitate the thermoforming process, provide improved mechanical and optical properties, and have a better resistance to sterilization. Manufactured in strict compliance with GMP standards and support regulatory compliance needs, Evercare™ films are offered with declarations such as ISO10993, USP661.1, ISO11607, as well as change notification.

Gonzalo Lopez-Oleaga, Evertis Europe Deputy CEO said; “This is another key milestone in the journeyof our Group of businesses. As innovators and thought leaders in polyester-based materials we are now positioned to help healthcare companies meet their sustainability packaging goals, now, and into the future. Behind Evercare™ we have made large investments operationally, in technology and most importantly GMP manufacturing supported by full certifications to service this market”.

Similar to other industries, the healthcare packaging industry faces the challenges of improving sustainability. This is why the Evercare product range not only offers plug&play recyclable PET based solutions, but also two other sustainable options: bio-based and chemically recycled materials with up to 50% post-consumer recycled (PCR) content. All of these options take advantage of vertical integration with Selenis, meeting the same quality and regulatory standards and representing a great opportunity to lower carbon footprint.

Casimiro Sacchetti, CSO Evertis Americas said; “It’s an exciting and unique offering for the Healthcare market. It’s the coming together of experience, deep technical knowledge underpinned by a truly integrated, vertical operational set-up from resin production to extrusion of medical-grade films. With the innovative Evercare™ film range we are actively supporting the move of our medical & pharma customers towards safe and ecofriendly packaging solutions.”

June 2024

Evertis launches Evercare™ brand, set to be a leading provider of specialty and innovative medical-gradefilms designed to provide superior performance and support regulatory compliance to the healthcare market. Evercare™ is built on over 65 years of trusted technical Evertis experience in developing PET and PETG films for regulated applications that meet sustainability credentials, and now compliant in meeting the rigorous needs of the healthcare industry.

Evercare™ sits in avertically integrated Group that delivers a unique value proposition to Healthcare customers in terms of innovation, sustainability and supply chain security. As film converters for packaging, Evertis is integrated with Selenis,a premium supplier of innovative copolyesters resins with solutions specifically developed, and certified for the medical value chain to further support patient safety. As a Group it fully understands and plays its part in circularity whilst reducing the carbon footprint of its products.

Evercare™ PET and PETG drop-in solutions offer performance and sustainability advantages when compared to other materials. Their films facilitate the thermoforming process, provide improved mechanical and optical properties, and have a better resistance to sterilization. Manufactured in strict compliance with GMP standards and support regulatory compliance needs, Evercare™ films are offered with declarations such as ISO10993, USP661.1, ISO11607, as well as change notification.

Gonzalo Lopez-Oleaga, Evertis Europe Deputy CEO said; “This is another key milestone in the journeyof our Group of businesses. As innovators and thought leaders in polyester-based materials we are now positioned to help healthcare companies meet their sustainability packaging goals, now, and into the future. Behind Evercare™ we have made large investments operationally, in technology and most importantly GMP manufacturing supported by full certifications to service this market”.

Similar to other industries, the healthcare packaging industry faces the challenges of improving sustainability. This is why the Evercare product range not only offers plug&play recyclable PET based solutions, but also two other sustainable options: bio-based and chemically recycled materials with up to 50% post-consumer recycled (PCR) content. All of these options take advantage of vertical integration with Selenis, meeting the same quality and regulatory standards and representing a great opportunity to lower carbon footprint.

Casimiro Sacchetti, CSO Evertis Americas said; “It’s an exciting and unique offering for the Healthcare market. It’s the coming together of experience, deep technical knowledge underpinned by a truly integrated, vertical operational set-up from resin production to extrusion of medical-grade films. With the innovative Evercare™ film range we are actively supporting the move of our medical & pharma customers towards safe and ecofriendly packaging solutions.”

June 2024

Evertis launches Evercare™ brand, set to be a leading provider of specialty and innovative medical-gradefilms designed to provide superior performance and support regulatory compliance to the healthcare market. Evercare™ is built on over 65 years of trusted technical Evertis experience in developing PET and PETG films for regulated applications that meet sustainability credentials, and now compliant in meeting the rigorous needs of the healthcare industry.

Evercare™ sits in avertically integrated Group that delivers a unique value proposition to Healthcare customers in terms of innovation, sustainability and supply chain security. As film converters for packaging, Evertis is integrated with Selenis,a premium supplier of innovative copolyesters resins with solutions specifically developed, and certified for the medical value chain to further support patient safety. As a Group it fully understands and plays its part in circularity whilst reducing the carbon footprint of its products.

Evercare™ PET and PETG drop-in solutions offer performance and sustainability advantages when compared to other materials. Their films facilitate the thermoforming process, provide improved mechanical and optical properties, and have a better resistance to sterilization. Manufactured in strict compliance with GMP standards and support regulatory compliance needs, Evercare™ films are offered with declarations such as ISO10993, USP661.1, ISO11607, as well as change notification.

Gonzalo Lopez-Oleaga, Evertis Europe Deputy CEO said; “This is another key milestone in the journeyof our Group of businesses. As innovators and thought leaders in polyester-based materials we are now positioned to help healthcare companies meet their sustainability packaging goals, now, and into the future. Behind Evercare™ we have made large investments operationally, in technology and most importantly GMP manufacturing supported by full certifications to service this market”.

Similar to other industries, the healthcare packaging industry faces the challenges of improving sustainability. This is why the Evercare product range not only offers plug&play recyclable PET based solutions, but also two other sustainable options: bio-based and chemically recycled materials with up to 50% post-consumer recycled (PCR) content. All of these options take advantage of vertical integration with Selenis, meeting the same quality and regulatory standards and representing a great opportunity to lower carbon footprint.

Casimiro Sacchetti, CSO Evertis Americas said; “It’s an exciting and unique offering for the Healthcare market. It’s the coming together of experience, deep technical knowledge underpinned by a truly integrated, vertical operational set-up from resin production to extrusion of medical-grade films. With the innovative Evercare™ film range we are actively supporting the move of our medical & pharma customers towards safe and ecofriendly packaging solutions.”

June 2024

Evertis launches Evercare™ brand, set to be a leading provider of specialty and innovative medical-gradefilms designed to provide superior performance and support regulatory compliance to the healthcare market. Evercare™ is built on over 65 years of trusted technical Evertis experience in developing PET and PETG films for regulated applications that meet sustainability credentials, and now compliant in meeting the rigorous needs of the healthcare industry.

Evercare™ sits in avertically integrated Group that delivers a unique value proposition to Healthcare customers in terms of innovation, sustainability and supply chain security. As film converters for packaging, Evertis is integrated with Selenis,a premium supplier of innovative copolyesters resins with solutions specifically developed, and certified for the medical value chain to further support patient safety. As a Group it fully understands and plays its part in circularity whilst reducing the carbon footprint of its products.

Evercare™ PET and PETG drop-in solutions offer performance and sustainability advantages when compared to other materials. Their films facilitate the thermoforming process, provide improved mechanical and optical properties, and have a better resistance to sterilization. Manufactured in strict compliance with GMP standards and support regulatory compliance needs, Evercare™ films are offered with declarations such as ISO10993, USP661.1, ISO11607, as well as change notification.

Gonzalo Lopez-Oleaga, Evertis Europe Deputy CEO said; “This is another key milestone in the journeyof our Group of businesses. As innovators and thought leaders in polyester-based materials we are now positioned to help healthcare companies meet their sustainability packaging goals, now, and into the future. Behind Evercare™ we have made large investments operationally, in technology and most importantly GMP manufacturing supported by full certifications to service this market”.

Similar to other industries, the healthcare packaging industry faces the challenges of improving sustainability. This is why the Evercare product range not only offers plug&play recyclable PET based solutions, but also two other sustainable options: bio-based and chemically recycled materials with up to 50% post-consumer recycled (PCR) content. All of these options take advantage of vertical integration with Selenis, meeting the same quality and regulatory standards and representing a great opportunity to lower carbon footprint.

Casimiro Sacchetti, CSO Evertis Americas said; “It’s an exciting and unique offering for the Healthcare market. It’s the coming together of experience, deep technical knowledge underpinned by a truly integrated, vertical operational set-up from resin production to extrusion of medical-grade films. With the innovative Evercare™ film range we are actively supporting the move of our medical & pharma customers towards safe and ecofriendly packaging solutions.”

June 2024

Evertis launches Evercare™ brand, set to be a leading provider of specialty and innovative medical-gradefilms designed to provide superior performance and support regulatory compliance to the healthcare market. Evercare™ is built on over 65 years of trusted technical Evertis experience in developing PET and PETG films for regulated applications that meet sustainability credentials, and now compliant in meeting the rigorous needs of the healthcare industry.

Evercare™ sits in avertically integrated Group that delivers a unique value proposition to Healthcare customers in terms of innovation, sustainability and supply chain security. As film converters for packaging, Evertis is integrated with Selenis,a premium supplier of innovative copolyesters resins with solutions specifically developed, and certified for the medical value chain to further support patient safety. As a Group it fully understands and plays its part in circularity whilst reducing the carbon footprint of its products.

Evercare™ PET and PETG drop-in solutions offer performance and sustainability advantages when compared to other materials. Their films facilitate the thermoforming process, provide improved mechanical and optical properties, and have a better resistance to sterilization. Manufactured in strict compliance with GMP standards and support regulatory compliance needs, Evercare™ films are offered with declarations such as ISO10993, USP661.1, ISO11607, as well as change notification.

Gonzalo Lopez-Oleaga, Evertis Europe Deputy CEO said; “This is another key milestone in the journeyof our Group of businesses. As innovators and thought leaders in polyester-based materials we are now positioned to help healthcare companies meet their sustainability packaging goals, now, and into the future. Behind Evercare™ we have made large investments operationally, in technology and most importantly GMP manufacturing supported by full certifications to service this market”.

Similar to other industries, the healthcare packaging industry faces the challenges of improving sustainability. This is why the Evercare product range not only offers plug&play recyclable PET based solutions, but also two other sustainable options: bio-based and chemically recycled materials with up to 50% post-consumer recycled (PCR) content. All of these options take advantage of vertical integration with Selenis, meeting the same quality and regulatory standards and representing a great opportunity to lower carbon footprint.

Casimiro Sacchetti, CSO Evertis Americas said; “It’s an exciting and unique offering for the Healthcare market. It’s the coming together of experience, deep technical knowledge underpinned by a truly integrated, vertical operational set-up from resin production to extrusion of medical-grade films. With the innovative Evercare™ film range we are actively supporting the move of our medical & pharma customers towards safe and ecofriendly packaging solutions.”